Epsilon M&A Deal Report - V Plus (Laboratoires Vivacy)
Transaction Multiples for the Valuation of Private Companies
Bloomage Biotechnology Corporation / V Plus (Laboratoires Vivacy)
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
||||||
Current | ![]() |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
Date | Acquirer | Target | Country | Multiples | See details |
30/07/2015 | Ascendis Health | Farmalider | Spain | ** | 76407 |
30/11/2015 | Almirall | Poli Group | Italy | ** | 76394 |
Source: Epsilon Research / EMAT